NCT00132158View on ClinicalTrials.gov

ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

GlioblastomaRhabdomyosarcomasNeuroblastomaOsteosarcoma

Interventions

DRUG

Irinotecan (Camptosar), Gefitinib (Iressa)

See Detailed Description for treatment plan.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

St. Jude Children's Research Hospital

OTHER